0.2970USD+7.73%Mkt Cap: 5.98M $P/E: —2d ago
Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), …
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap5.98M $
Enterprise Value17.28M $
Revenue (TTM)20.90M $
Gross Profit10.54M $
Net Income (TTM)-21.23M $
Revenue/Share1.500 USD
Last Price0.2970 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees268
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.34
PEG—
EV/EBITDA-0.83
EV/Revenue0.83
P/S0.27
P/B0.91
EPS (TTM)-1.89
EPS (Forward)-0.82
52W Range
0.26041% of range5.120
52W High5.120 USD
52W Low0.2604 USD
Profitability
Gross Margin60.44%
Oper. Margin-93.64%
EBITDA Margin-99.33%
Profit Margin-121.71%
ROE1424.83%
ROA-84.41%
Growth
Revenue Growth34.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-15.26M $
CapEx (TTM)2.34M $
FCF Margin-35.34%
FCF Yield-123.63%
Net Debt10.73M $
Net Debt/EBITDA-0.52
Balance Sheet
Debt/Equity-9.06
Current Ratio0.21
Quick Ratio0.16
Book Value/Sh0.3060 USD
Cash/Share0.0880 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:25
Split DateOct 27, 2023
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)2.117 USD
Upside (mean)+612.7%
Target Range0.7500 USD – 3.100 USD
$0.7500+612.7% to mean$3.100
# Analysts3
Ownership
Shares Out.20.12M
Float14.94M
Insiders27.20%
Institutions6.51%
Short Interest
Short Ratio1.6d
Short % Float10.81%
Short % Out.8.65%
Shares Short1.20M
Short (prev mo.)1.17M
Technical
SMA 500.4224 (-29.7%)
SMA 2001.254 (-76.3%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)1.27M
Avg Vol (10d)1.33M
Technical Indicators
RSI (14)37.9
MACD-0.0443
MACD Signal-0.0428
MACD Hist.-0.0015
BB Upper0.4690 USD
BB Middle0.3573 USD
BB Lower0.2457 USD
BB Width62.49%
ATR (14)0.0488 USD
Vol Ratio (20d)0.06x